Open access
Aug 2026
Performance of PREMM5, clinical criteria, and immunohistochemistry for MMR proteins in genetic risk assessment of Mexican patients with colorectal cancer
Considering the spectrum of PVs identified, employing a multigene panel test is recommended for Mexican patients with CRC, and the performance of PREMM5 in this Mexican cohort was comparable to findings reported in validation studies within other populations.
J. L. Rodríguez-Olivares, D. Aguilar-y-Mendez, Tamara N. Kimball et al.
· PLoS ONE · 0 citations